Navigation Links
Orthofeet Expands Sales and Operations Management

NORTHVALE, N.J., Nov. 14, 2011 /PRNewswire/ -- Orthofeet, a leading manufacturer of premium quality therapeutic footwear, today announced a new sales and operations management team, comprised of hires and internal promotions.  The seasoned team represents the first internal changes since the new executive leadership was established last July.

Joining Orthofeet will be Charles Liberge as Vice President, Business Development and Cyndee Fitzsimmons, Director of Sales.  Additionally, Mike Saccente is promoted to Director, NJ Operations and Paul Barattiero, C. Ped., is appointed to VP, Sales Training and Development.

"We are confident that we've put into place the right mix of executives and a highly effective structure to help achieve our growth aspirations," said Mark Koide, CEO, Orthofeet.  "This collective group combines long term Orthofeet operational expertise with professionals who have consistently demonstrated their ability to grow businesses and build brands."

Well regarded as a footwear industry leader, Charles Liberge comes to Orthofeet with extensive experience in all aspects of developing and managing growth oriented organizations, including success at Stride Rite, Earth Brand Footwear, KangaROOS and Klas Shoes.  In his new role, Mr. Liberge will oversee strategy and execution over a number of business initiatives that have high growth potential and require highly focused resources.

Cyndee Fitzsimmons joins the company from P.W. Minor where she was Director, Sales.  Her responsibilities will include the development and management of corporate sales plans, including inside sales management and forecasting.

Mike Saccente is a 20-year Orthofeet veteran, having worked in multiple Operations positions within the company.  Mr. Saccente will continue to oversee customer service and will now be responsible for warehousing and transportation.

Paul Barattiero has been with Orthofeet for 4 years and will now be responsible for training and development of the company's staff and representatives, external education programs, research and tradeshows.

Orthofeet is the premium brand of specialty footwear biomechanically designed to provide consumers with ultimate mobility, comfort and protection for an improved quality of life.  The company was established in 1985 by the Bar brothers, two biomedical engineers who pioneered innovations in footwear construction unmatched in the industry.  In order to maintain its high level of quality and service, Orthofeet produces most of its products through company owned plants. Orthofeet partners with medical professionals and DME providers throughout the US to provide patients with a great selection of therapeutic shoes, insoles and socks. For more information visit

SOURCE Orthofeet
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo Expands Infant Formula Distribution in China With Brilite Nutritionals (Shanghai) Co., Ltd.
2. Regulus Therapeutics Expands Worldwide Patent Coverage on microRNA-122 to Treat Hepatitis C Virus (HCV) Infection
3. Baxano Rapidly Expands Sales Force to Support Robust Demand for the iO-Flex® System
4. PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value
5. CPhI Global Portfolio Expands into South East Asia
6. Awarepoint Expands Senior Management Team
7. Perrigo Expands Infant Formula Distribution in China With Founder Group
8. GTX Corp Expands Partner Alliance in Preparation for GPS Shoe Launch
9. GNS Healthcare, Inc. Expands Senior Management Team to Leverage the Rapidly Growing Opportunities for Big Data in Healthcare Management
10. Fujifilm Expands FDR D-EVO™ Wireless Product Line With New 17x17 Inch Detector
11. Inogens Home Oxygen Therapy Service Expands to Florida
Post Your Comments:
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. ... big data solutions, today announced that its MyDario product is expected to ... TV listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, ... ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
Breaking Medicine News(10 mins):